Pricing Log in Create free account

Edesa Biotech, Inc. (EDSA) vs Lite Strategy, Inc. (LITS)

Edesa Biotech, Inc. and Lite Strategy, Inc. are both Biotechnology companies. Edesa Biotech, Inc. and Lite Strategy, Inc. are of similar size ($36.3M and $36.1M). Lite Strategy, Inc. grew revenue faster over the last twelve months: 152.9% against −43.5%. Across the 13 metrics below, Lite Strategy, Inc. leads on 8 and Edesa Biotech, Inc. on 5.

Valuation

Metric EDSA LITS Biotechnology median
P/E n/m n/m 8.50
P/S 70.40 0.37 9.71
P/B 58.02 0.95 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 38.98 0.32 9.21
Earnings yield (65.76%) (179.62%) (33.15%)
Free cash flow yield (38.51%) (264.16%) (25.50%)

Profitability

Metric EDSA LITS Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (531.32%) (243.02%) (56.36%)
Return on assets (102.46%) (233.37%) (48.04%)
Return on invested capital 0.00% (115.85%) 0.00%

Growth

Metric EDSA LITS Biotechnology median
Revenue growth (TTM) (43.48%) 152.90% 6.02%
EPS growth (last fiscal year) 34.20% 13.86% 30.26%
Revenue growth, 5-year CAGR (15.40%) 67.75% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EDSA LITS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.76 5.74 4.72
Net debt to EBITDA 1.39 0.09 0.96

Dividend

Metric EDSA LITS Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric EDSA LITS Biotechnology median
Market cap 36.08m 36.34m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack